MedTrace Logo

Controlling Hypertension in Native American and Other Populations

NCT03135405 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 295

Last updated 2019-05-09

No results posted yet for this study

Summary

The study evaluates the use of automated motivational messages, visit reminders, and medication reminders (using interactive voice response technology or text messages) to improve blood pressure control among adults with hypertension that receive their care at the First Nations Community Healthsource clinic in Albuquerque, New Mexico. Half of the participants will receive usual care, while the other half will receive the automated calls or text messages and have the option to receive home blood pressure monitors and/or designate a care partner who will also receive messages. Participants will be followed for 12 months.

Conditions

Interventions

BEHAVIORAL

Automated messages

Automated motivational messages and visit and medication reminders will be provided via interactive voice response calls or text messages.

BEHAVIORAL

Home BP monitors

Participants will have the option of receiving home blood pressure monitors.

BEHAVIORAL

Care partner reminders

Participants will have the option of designating a care partner who will also receive automated reminder calls or text messages.

Sponsors & Collaborators

  • American Heart Association

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    collaborator NIH

  • University of Colorado, Denver

    collaborator OTHER

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Emily B Schroeder, MD, PhD · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-11
Primary Completion
2019-02-28
Completion
2019-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03135405 on ClinicalTrials.gov